JPWO2021182570A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021182570A5
JPWO2021182570A5 JP2021532005A JP2021532005A JPWO2021182570A5 JP WO2021182570 A5 JPWO2021182570 A5 JP WO2021182570A5 JP 2021532005 A JP2021532005 A JP 2021532005A JP 2021532005 A JP2021532005 A JP 2021532005A JP WO2021182570 A5 JPWO2021182570 A5 JP WO2021182570A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021532005A
Other languages
English (en)
Japanese (ja)
Other versions
JP7793986B2 (ja
JPWO2021182570A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/009795 external-priority patent/WO2021182570A1/ja
Publication of JPWO2021182570A1 publication Critical patent/JPWO2021182570A1/ja
Publication of JPWO2021182570A5 publication Critical patent/JPWO2021182570A5/ja
Application granted granted Critical
Publication of JP7793986B2 publication Critical patent/JP7793986B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021532005A 2020-03-12 2021-03-11 癌の治療及び/又は予防のための医薬品 Active JP7793986B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020043018 2020-03-12
JP2020043018 2020-03-12
PCT/JP2021/009795 WO2021182570A1 (ja) 2020-03-12 2021-03-11 癌の治療及び/又は予防のための医薬品

Publications (3)

Publication Number Publication Date
JPWO2021182570A1 JPWO2021182570A1 (https=) 2021-09-16
JPWO2021182570A5 true JPWO2021182570A5 (https=) 2024-02-28
JP7793986B2 JP7793986B2 (ja) 2026-01-06

Family

ID=77670659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021532005A Active JP7793986B2 (ja) 2020-03-12 2021-03-11 癌の治療及び/又は予防のための医薬品

Country Status (7)

Country Link
US (1) US20230139178A1 (https=)
EP (1) EP4119157A4 (https=)
JP (1) JP7793986B2 (https=)
KR (1) KR20220153621A (https=)
BR (1) BR112022018163A2 (https=)
CA (1) CA3175277A1 (https=)
WO (1) WO2021182570A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101638490B1 (ko) * 2008-08-05 2016-07-11 도레이 카부시키가이샤 암의 치료 및 예방용 의약 조성물
AU2022298240A1 (en) * 2021-06-23 2024-01-18 Toray Industries, Inc. Medicament for treatment and/or prevention of cancer

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
US6677436B1 (en) 1998-04-03 2004-01-13 Chugai Seiyaku Kabushiki Kaisha Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
ES2434961T5 (es) 1998-04-20 2018-01-18 Roche Glycart Ag Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
EP1176195B1 (en) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
JP2006524039A (ja) 2003-01-09 2006-10-26 マクロジェニクス,インコーポレーテッド 変異型Fc領域を含む抗体の同定および作製ならびにその利用法
US8388955B2 (en) 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
DE10359795A1 (de) 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Strangverdampfervorrichtung
KR101638490B1 (ko) * 2008-08-05 2016-07-11 도레이 카부시키가이샤 암의 치료 및 예방용 의약 조성물
AU2010270979B2 (en) 2009-06-22 2015-04-23 Medimmune, Llc Engineered Fc regions for site-specific conjugation
SG178925A1 (en) 2009-09-22 2012-04-27 Volker Sandig Process for producing molecules containing specialized glycan structures
KR101842893B1 (ko) * 2010-02-04 2018-03-28 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
HUE025678T2 (en) 2010-02-04 2016-04-28 Toray Industries A pharmaceutical composition for the treatment and / or prevention of cancer
MX340015B (es) * 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
BR112012018943A8 (pt) 2010-02-04 2017-12-19 Toray Industries medicamento e método para o tratamento e/ou prevenção de um câncer
RU2598258C2 (ru) 2010-02-04 2016-09-20 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
MX342291B (es) 2010-02-04 2016-09-23 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
BR112012024489A2 (pt) 2010-03-29 2016-05-31 Zymeworks Inc anticorpos com função efetora suprimida ou aumentada
US9181348B2 (en) * 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
RU2595400C2 (ru) * 2011-08-04 2016-08-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
PT2740794T (pt) 2011-08-04 2018-06-14 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
KR102041832B1 (ko) 2011-08-04 2019-11-08 도레이 카부시키가이샤 췌장암의 치료 및/또는 예방용 의약 조성물
PT2740793T (pt) * 2011-08-04 2018-02-23 Toray Industries Composição de fármacos para o tratamento e/ou a prevenção de cancro
JP6070191B2 (ja) 2011-08-04 2017-02-01 東レ株式会社 癌の治療及び/又は予防用医薬組成物
HUE044611T2 (hu) 2012-02-21 2019-11-28 Toray Industries Gyógyászati készítmény rák kezelésére
PT2818483T (pt) * 2012-02-21 2017-10-09 Toray Industries Composição medicinal para tratamento e/ou prevenção de cancro
US9260513B2 (en) * 2012-02-21 2016-02-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
BR112014021103A2 (pt) 2012-02-21 2019-10-15 Toray Industries, Inc Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
PT2832366T (pt) 2012-03-30 2018-01-25 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
KR102155531B1 (ko) 2012-03-30 2020-09-15 도레이 카부시키가이샤 간암의 치료 및/또는 예방용 의약 조성물
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
ES2704909T3 (es) 2013-08-09 2019-03-20 Toray Industries Composición farmacéutica para el tratamiento y/o la prevención del cáncer
JP6320040B2 (ja) * 2013-12-27 2018-05-09 国立大学法人福井大学 抗prok1抗体及び抗vegf抗体併用による大腸癌の治療
JP7342701B2 (ja) * 2018-03-30 2023-09-12 東レ株式会社 癌の治療及び/又は予防用医薬組成物
JP2020043018A (ja) 2018-09-12 2020-03-19 三菱製紙株式会社 リチウムイオン二次電池
AU2022298240A1 (en) * 2021-06-23 2024-01-18 Toray Industries, Inc. Medicament for treatment and/or prevention of cancer

Similar Documents

Publication Publication Date Title
JPWO2021182573A5 (https=)
AU2019242520B2 (en) Pharmaceutical composition for treatment and/or prevention of cancer
CN119789868A (zh) 用于癌的治疗和/或预防的药品
HRP20201848T1 (hr) Bispecifična egfr/c-met antitijela
JP7797875B2 (ja) 癌の治療及び/又は予防のための医薬品
US20250228937A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182570A5 (https=)
WO2025080769A1 (en) Methods of treating cancer
JPWO2021182571A5 (https=)
JPWO2021182574A5 (https=)
JP7793986B2 (ja) 癌の治療及び/又は予防のための医薬品
JP7715041B2 (ja) 癌の治療及び/又は予防のための医薬品
JPWO2021182572A5 (https=)
EP4119160A1 (en) Medicament for treatment and/or prevention of cancer
JP7793985B2 (ja) 癌の治療及び/又は予防のための医薬品
EP4422757A1 (en) Methods of using anti-egf antibodies to augment the activity of braf and kras inhibitors
EP4360648A1 (en) Medicament for treatment and/or prevention of cancer
EP4582101A1 (en) Medicament for treatment and/or prevention of cancer
US20260115285A1 (en) Medicament for treatment and/or prevention of cancer
EP4578458A1 (en) Medicament for treatment and/or prevention of cancer
EP4378476A1 (en) Medicament for treatment and/or prevention of cancer
US20260115267A1 (en) Methods of using anti-egf antibodies to augment the activity of braf and kras inhibitors
EP4640235A1 (en) Medicament for treatment and/or prevention of cancer